Maravai LifeSciences Files 8-K on Shareholder Vote Matters

TL;DR

MRVI filed an 8-K for a shareholder vote on 5/23. All good.

AI Summary

Maravai LifeSciences Holdings, Inc. filed an 8-K on May 28, 2024, reporting on matters submitted to a vote of security holders on May 23, 2024. The filing details the company's corporate structure, including its incorporation in Delaware and its principal executive offices located in San Diego, California.

Why It Matters

This filing informs shareholders about important decisions made during a vote, impacting corporate governance and potentially future company strategy.

Risk Assessment

Risk Level: low — This is a routine filing reporting on a shareholder vote, with no immediate financial or operational risks indicated.

Key Numbers

• 001-39725 — SEC File Number (Identifies the company's filing with the SEC.)
• 85-2786970 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• MARAVAI LIFESCIENCES HOLDINGS, INC. (company) — Registrant
• May 23, 2024 (date) — Date of earliest event reported
• May 28, 2024 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• San Diego, California (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — which registered Class A Common Stock, $0.01 par value MRVI The Nasdaq Stock Market

Filing Documents

• mrvi-20240523.htm (8-K) — 38KB
• 0001823239-24-000082.txt ( ) — 162KB
• mrvi-20240523.xsd (EX-101.SCH) — 2KB
• mrvi-20240523_lab.xml (EX-101.LAB) — 22KB
• mrvi-20240523_pre.xml (EX-101.PRE) — 13KB
• mrvi-20240523_htm.xml (XML) — 3KB

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. On May 23, 2024, Maravai LifeSciences Holdings, Inc. (the "Company") held its 2024 Annual Meeting of Shareholders (the "Annual Meeting"). On March 25, 2024, the record date for the Annual Meeting, the Company had an aggregate of 251,748,827 shares of common stock issued and outstanding, consisting of 132,654,801 shares of Class A common stock and 119,094,026 shares of Class B common stock (together, the "Common Stock"). The holders of a total of 236,931,940 shares of Common Stock were present at the Annual Meeting, either in person or by proxy, which constituted a quorum for the purpose of conducting business at the Annual Meeting. Set forth below are the final voting results for each proposal submitted to a vote of the Company's shareholders at the Annual Meeting. Proposal No. 1: Election of directors. The Company's shareholders elected the following nominees for director to serve for three-year terms expiring at the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal. Nominee Votes For Votes Withheld Broker Non-Votes Benjamin Daverman 193,739,240 33,663,940.90 9,528,759.10 Susannah Gray 193,773,793 33,629,387.90 9,528,759.10 Carl Hull 196,078,626 31,324,554.90 9,528,759.10 Constantine Mihas 191,415,297 35,987,883.90 9,528,759.10 Proposal No. 2: Proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 was ratified by the Company's shareholders. Votes For Votes Against Abstentions 236,288,478 268,742 374,720 Proposal No. 3: Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named exe

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MARAVAI LIFESCIENCES HOLDINGS, INC. Date: May 28, 2024 By: /s/ Kevin M. Herde Name: Kevin M. Herde Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR